LYTIR

Company · KNSA

Kiniksa Pharmaceuticals International, plc

Nasdaq's symbol directory lists KNSA on Nasdaq as “Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares”.

In the 12 months to Nov 8, 2026: insiders sold on 12 occasions ($77.8M); 5 planned-sale notices; 2 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC · Appeared in No. 42, No. 41, No. 40, No. 39, No. 38

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $77.8M in total.Jul: Insider sales $299KSep: Insider sales $369KOct: Insider sales $26.3MNov: Insider sales $50.8MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $77.8M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Patel Sanj K, CHAIRMAN & CEO sold on 4 days all under a 10b5-1 plan latest Nov 4, 2026 sold $51.7M
  2. Moat Ross, CHIEF OPERATING OFFICER sold on 2 days all under a 10b5-1 plan latest Nov 2, 2026 sold $9.6M
  3. Paolini John F., CHIEF MEDICAL OFFICER sold on 2 days all under a 10b5-1 plan latest Nov 2, 2026 sold $8.9M
  4. Megna Michael R, CHIEF ACCOUNTING OFFICER sold on 2 days all under a 10b5-1 plan latest Oct 30, 2026 sold $3.8M
  5. Ragosa Mark, CHIEF FINANCIAL OFFICER sold on 1 day all under a 10b5-1 plan latest Nov 2, 2026 sold $3.4M
  6. Cole G Bradley sold on 1 day latest Jul 29, 2026 sold $299K
Every trade (12)
  1. SELLPatel Sanj K, CHAIRMAN & CEO sold Nov 4, 2026 151,300 shares 5 legs combined 10b5-1 plan (scheduled) filing $14.3M
  2. SELLPatel Sanj K, CHAIRMAN & CEO sold Nov 3, 2026 220,170 shares 4 legs combined 10b5-1 plan (scheduled) filing $20.5M
  3. SELLPatel Sanj K, CHAIRMAN & CEO sold Nov 2, 2026 89,433 shares 4 legs combined 10b5-1 plan (scheduled) filing $8.2M
  4. SELLRagosa Mark, CHIEF FINANCIAL OFFICER sold Nov 2, 2026 36,783 shares 4 legs combined 10b5-1 plan (scheduled) filing $3.4M
  5. SELLMoat Ross, CHIEF OPERATING OFFICER sold Nov 2, 2026 27,977 shares 4 legs combined 10b5-1 plan (scheduled) filing $2.6M
  6. SELLPaolini John F., CHIEF MEDICAL OFFICER sold Nov 2, 2026 18,413 shares 3 legs combined 10b5-1 plan (scheduled) filing $1.7M
  7. SELLPatel Sanj K, CHAIRMAN & CEO sold Oct 30, 2026 92,891 shares 7 legs combined 10b5-1 plan (scheduled) filing $8.6M
  8. SELLPaolini John F., CHIEF MEDICAL OFFICER sold Oct 30, 2026 77,587 shares 7 legs combined 10b5-1 plan (scheduled) filing $7.2M
  9. SELLMoat Ross, CHIEF OPERATING OFFICER sold Oct 30, 2026 75,608 shares 7 legs combined 10b5-1 plan (scheduled) filing $7.0M
  10. SELLMegna Michael R, CHIEF ACCOUNTING OFFICER sold Oct 30, 2026 36,260 shares 7 legs combined 10b5-1 plan (scheduled) filing $3.4M
  11. SELLMegna Michael R, CHIEF ACCOUNTING OFFICER sold Sep 3, 2026 4,600 shares 10b5-1 plan (scheduled) filing $369K
  12. SELLCole G Bradley sold Jul 29, 2026 3,673 shares filing $299K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. Ragosa Mark filed Nov 2, 2026 Officer 36,783 shares planned sale date 11/02/2026 filing $3.4M
  2. Patel Sanj K filed Oct 30, 2026 Officer 553,794 shares planned sale date 10/30/2026 filing $51.6M
  3. Moat Ross filed Oct 30, 2026 Officer 103,585 shares planned sale date 10/30/2026 filing $9.8M
  4. Paolini John F. filed Oct 30, 2026 Officer 96,000 shares planned sale date 10/30/2026 filing $8.9M
  5. Megna Michael R filed Oct 30, 2026 Officer 47,540 shares planned sale date 10/30/2026 filing $4.6M

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Oct 27, 2026
  2. Departure or appointment of directors or officers filing Oct 22, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.